Latest / Oncology Data Advisor
Assessing Risk of Myelosuppression With PARP Inhibitors in Prostate Cancer: Karan Jatwani, MBBS
Assessing Risk of Myelosuppression With PARP Inhibitors in Prostate Cancer: Karan Jatwani, MBBS by i3 Health
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.